30th Annual International Prostate Cancer Update

Beaver Creek, Colorado
January 23-26, 2020

Note: The International Bladder Cancer Update will be in October 2020.

PROGRAM OVERVIEW
The International Prostate Cancer Update (IPCU), founded in 1990, is a multi-day CME conference focused on prostate cancer treatment updates with expert, international faculty. IPCU 30 will encompass expert lectures, interactive discussions, a panel roundtable, debates, and case reports.  This conference is led by expert physicians and is designed for urologists, medical oncologists, radiation oncologists, and other healthcare professionals involved in the diagnosis and treatment of prostate cancer.

The goal of this educational program is to equip healthcare professionals involved in the diagnosis and treatment of prostate cancer with the up-to-date clinical knowledge and tools they need to best treat their patients. The program will discuss the treatment of prostate cancer from diagnosis to treating advanced and metastatic disease. The conference aims to give physicians exposure to a comprehensive review of treating prostate cancer patients, and to give them a chance to discuss the issues with peers and experts.

Objectives
At the conclusion of this activity, the participant should be able to:

  • Discuss the experiences of both urologists and oncologists in various practice settings to improve patient outcomes by integrating a team approach to treatment.
  • Evaluate and summarize newly-approved therapies for advanced prostate cancer.
  • Discuss treatment options for localized prostate cancer.
  • Investigate strategies to improve and integrate nutrition, exercise, and counseling on adverse effects into the management of prostate cancer to  improve quality of life and psychological well-being of the patients.
  • Discuss the role of the urinary microbiome in relation to prostate cancer.

Target Audience
This activity is designed for urologists, medical oncologists, radiation oncologists, primary care physicians, residents, and other healthcare professionals involved in the diagnosis and management of prostate cancer.

Educational Method
Didactic, Panel Discussion, Question and Answer

Accreditation and Credit Designation
AMA PRA Category 1 Credit

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baylor College of Medicine designates this live activity for a maximum of 16.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Evaluation
Evaluation by questionnaire will address program content, presentation, and possible bias.

SPECIAL FEATURE:
View faculty interviews from the 29th Annual International Prostate Cancer Update

 

Program Director

E. DAVID CRAWFORD, MD
Professor of Urology
University of California, San Diego
San Diego, California

LUGPA is pleased to co-sponsor the 30th annual International Prostate Cancer Update (IPCU) with Grand Rounds in Urology™ in 2020. LUGPA members receive a discount on regular or onsite registration.